MTDH Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of MTDH Antibodies for investigating metadherin function and expression. Monoclonal MTDH Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MTDH, also known as metadherin, is a multifunctional protein involved in cell proliferation, migration, and survival. Research has shown MTDH plays significant roles in cancer development, particularly in tumor progression and metastasis. Understanding MTDH function continues to be a key focus in cancer research and therapeutic development. Monoclonal MTDH Antibodies enable precise detection and analysis of metadherin in various experimental settings. Researchers can utilize multiple formats, including antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Advanced research with MTDH Antibodies contributes to uncovering new therapeutic targets and developing innovative treatment strategies. Santa Cruz Biotechnology monoclonal MTDH Antibodies support researchers worldwide in advancing scientific understanding of cancer biology and potential therapeutic interventions.